Cargando…

Differential diagnosis and management of immune checkpoint inhibitor-induced colitis: A comprehensive review

Immune checkpoint inhibitors (ICIs) are a new class of cancer pharmacotherapy consisting of antibodies that block inhibitory immune regulators such as cytotoxic T lymphocyte antigen 4, programmed cell death 1 and programmed death-ligand 1. Checkpoint blockade by ICIs reactivates a tumor-specific T c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Hua, Fu, Zhi-Yan, Arslan, Mustafa Erdem, Cho, Daniel, Lee, Hwajeong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553980/ https://www.ncbi.nlm.nih.gov/pubmed/36246150 http://dx.doi.org/10.5493/wjem.v11.i6.79

Ejemplares similares

Plexiform fibromyxoma: Review of rare mesenchymal gastric neoplasm and its differential diagnosis
por: Arslan, Mustafa Erdem, et al.
Publicado: (2021)

Immune checkpoint inhibitor-induced colitis: A comprehensive review
por: Som, Aniruddh, et al.
Publicado: (2019)

Hepatic Langerhans cell histiocytosis: A review
por: Fu, Zhiyan, et al.
Publicado: (2021)

Immune checkpoint inhibitor-induced diarrhea/colitis: Endoscopic and pathologic findings
por: Nishida, Tsutomu, et al.
Publicado: (2019)

Immune checkpoint inhibitor-related hepatotoxicity: A review
por: Remash, Devika, et al.
Publicado: (2021)

Faecal microbiota transplantation enhances efficacy of immune checkpoint inhibitors therapy against cancer
por: Kang, Yong-Bo, et al.
Publicado: (2021)

Predicting response and toxicity to immune checkpoint inhibitors using routinely available blood and clinical markers
por: Hopkins, Ashley M, et al.
Publicado: (2017)

Composite intestinal adenoma-microcarcinoid: An update and literature review
por: Fu, Zhi-Yan, et al.
Publicado: (2021)

Checkpoint inhibitors: What gastroenterologists need to know
por: Ahmed, Monjur
Publicado: (2018)

Hallmarks of response to immune checkpoint blockade
por: Cogdill, Alexandria P, et al.
Publicado: (2017)

Hyperprogression under treatment with immune-checkpoint inhibitors in patients with gastrointestinal cancer: A natural process of advanced tumor progression?
por: Wang, Mo-Xuan, et al.
Publicado: (2022)

Radiotherapy as an immune checkpoint blockade combination strategy for hepatocellular carcinoma
por: Lee, Byung Min, et al.
Publicado: (2021)

Angiogenesis and immune checkpoint dual blockade: Opportunities and challenges for hepatocellular carcinoma therapy
por: Li, Si-Qi, et al.
Publicado: (2022)

Use of programmed cell death protein ligand 1 assay to predict the outcomes of non-small cell lung cancer patients treated with immune checkpoint inhibitors
por: Tibaldi, Carmelo, et al.
Publicado: (2017)

Update on hepatocellular carcinoma: Pathologists’ review
por: El Jabbour, Tony, et al.
Publicado: (2019)

The decatenation checkpoint
por: Damelin, M, et al.
Publicado: (2007)

Immune Checkpoint Inhibitor-Associated Colitis: From Mechanism to Management
por: Tang, Liansha, et al.
Publicado: (2021)

Benign vs malignant pancreatic lesions: Molecular insights to an ongoing debate
por: Aldyab, Mahmoud, et al.
Publicado: (2021)

Colon Adenoma After Diagnosis of Immune Checkpoint Inhibitor-mediated Colitis
por: Machado, Antonio Pizuorno, et al.
Publicado: (2023)

G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer
por: Bucher, N, et al.
Publicado: (2008)

Noninvasive diagnosis of periportal fibrosis in schistosomiasis mansoni: A comprehensive review
por: Santos, Joelma Carvalho, et al.
Publicado: (2022)

Immunometabolism: A target for the comprehension of immune response toward transplantation
por: Domínguez-Amorocho, Omar, et al.
Publicado: (2019)

Dabigatran in cardiovascular disease management: A comprehensive review
por: Javed, Ayesha, et al.
Publicado: (2021)

Immune Checkpoint Inhibitor-Induced Colitis Presenting As Lymphocytic Colitis
por: Khan, Jaffar, et al.
Publicado: (2021)

Relationship between non-alcoholic fatty liver disease and coronary heart disease
por: Arslan, Ugur, et al.
Publicado: (2020)

Immune Checkpoint Inhibitor-Associated Colitis and Hepatitis
por: Reddy, Haritha G., et al.
Publicado: (2018)

Mechanisms of Immune Checkpoint Inhibitor-Mediated Colitis
por: Westdorp, Harm, et al.
Publicado: (2021)

Diabetic foot ulcer: A comprehensive review of pathophysiology and management modalities
por: Raja, Joel M, et al.
Publicado: (2023)

Update on diagnosis and management of cuboid fractures
por: Angoules, Antonios G, et al.
Publicado: (2019)

Updates in diagnosis and management of pancreatic cysts
por: Lee, Linda S
Publicado: (2021)

Hamartomatous polyps: Diagnosis, surveillance, and management
por: Gorji, Leva, et al.
Publicado: (2023)

Diversion colitis and pouchitis: A mini-review
por: Tominaga, Kentaro, et al.
Publicado: (2018)

Gaseous metabolites as therapeutic targets in ulcerative colitis
por: Yao, Chu K, et al.
Publicado: (2023)

Non-clostridium difficile induced pseudomembranous colitis
por: Jagirdhar, Gowthami Sai Kogilathota, et al.
Publicado: (2023)

Takotsubo cardiomyopathy: Pathophysiology and role of cardiac biomarkers in differential diagnosis
por: Gopalakrishnan, Prabhakaran, et al.
Publicado: (2017)

Review of lymphoma in the duodenum: An update of diagnosis and management
por: Iwamuro, Masaya, et al.
Publicado: (2023)

Importance of endoscopic and histological evaluation in the management of immune checkpoint inhibitor-induced colitis
por: Abu-Sbeih, Hamzah, et al.
Publicado: (2018)

Regulatory roles of extracellular vesicles in immune responses against Mycobacterium tuberculosis infection
por: Yan, Zhi, et al.
Publicado: (2021)

Correction: Immune Checkpoint Inhibitor-Associated Colitis and Hepatitis
por: Reddy, Haritha G., et al.
Publicado: (2018)

Immune Checkpoint Inhibitor-Induced Acute Pancreatitis and Colitis
por: Pagan, Andrea, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o48eddrv8ajet7e110h2o7kjlj